Han JX, Koh MJ, Boussi L, et al. Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium. <i>Blood Adv</i> . 2025;9(3):583-602.

Publication Details

Journal
Blood Advances
Published
2025-11-25
DOI
https://doi.org/10.1182/bloodadvances.2025018400
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Han JX, Koh MJ, Boussi L, et al. Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium. Blood Adv . 2025;9(3):583-602.

Blood Advances
Lymphoma Diagnosis and Treatment
article

Han JX, Koh MJ, Boussi L, et al. Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium. Blood Adv . 2025;9(3):583-602.

article en

Abstract

No abstract available for this paper.
Blood AdvancesVol. 9(22)
Openalex Percentile: Top 50%
Lymphoma Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Han JX, Koh MJ, Boussi L, et al. Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium. <i>Blood Adv</i> . 2025;9(3):583-602. · Blood Advances (2025) | TGRS Research Map | TGRS